A murine model of bone marrow micrometastasis in breast cancer

Clinical and Experimental Metastasis

Volumn 19, Issue 7, 2002, Pages 561-569

  O'Kane Murphy, Barbara ^a,b   Joshi, Shantaram ^a   Kessinger, Anne ^a   Reed, Elizabeth ^a   Sharp, J Graham ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Bone marrow metastasis; Breast cancer; Mammary tumor; Murine model

Indexed keywords

CYTOKERATIN; GREEN FLUORESCENT PROTEIN; NEOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW METASTASIS; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER GROWTH; CANCER SURVIVAL; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC RESISTANCE; GENETIC TRANSDUCTION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; TUMOR CELL;

ADENOCARCINOMA; ANIMALS; BONE MARROW NEOPLASMS; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; GREEN FLUORESCENT PROTEINS; LUMINESCENT PROTEINS; MICE; MICE, INBRED BALB C; NEOPLASMS, EXPERIMENTAL; ORGAN SPECIFICITY; POLYMERASE CHAIN REACTION; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0036906643     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020958915361     Document Type: Article

References (61)

1. ACS. Cancer Facts and Figures: American Cancer Society, 2002.
2. ACS. Cancer facts and figures. CA Journal 2001; 51(1).
3. Hagemeister F, Buzdar A, Luna M et al. Causes of death in breast cancer: A clinopathological study. Cancer 1980; 46: 162-7.
4. Cho S, Choi H. Causes of death and metastatic patterns in patients with mammary cancer. Am J Clin Pathol 1980; 73: 232-234.
5. Kamby C. The pattern of metastases in human breast cancer: methodological aspects anal influence of prognostic factors. Cancer Treat Rev 1990; 17: 37-61.
6. Sharp JG, Vaughn W, Kessinger A et al. Significance of detection of tumor cells in hematopoietic stem cell harvests of patients with breast cancer. In: Dicke K, Armitage J and Dicke-Evinger MJ (eds): Proceedings of the 5th International Symposium on Autologous Bone Marrow Transplantation. University of Nebraska Medical Center, Omaha, Nebraska 1991; 385-92.
7. Mansi J, Easton D, Berger U et al. Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 year follow-up. Eur J Cancer 1991; 27: 1552-5.
8. Braun S, Pantel K, Muller P et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II or III breast cancer. N Engl J Med 2000; 342(8): 525-33.
9. Cote R, Rosen P, Lesser M et al. Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 1991; 9: 1749-56.
10. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889; 1: 571-3.
11. Hombauer H, Minguell J. Selective interactions between epithelial tumor cells and bone marrow mesenchymal cells. Br J Cancer 2000; 82(7): 1290-6.
12. Brooks B, Bundred N, Howell A et al. Investigation of mammary epithelial cell-bone marrow stroma interactions using primary human cell culture as a model of metastasis. Int J Cancer 1997; 73: 690-6.
13. Chirgwin J, Guise T. Molecular mechanisms of tumor-bone interactions in osteolytic metastases. Crit Rev Eukaryotic Gene Expression 2000; 12(2): 159-78.
14. Lelekakis M, Moseley J, Martin T et al. A novel model of breast cancer metastasis to bone. Clin Exp Metastasis 1999; 17: 163-70.
15. Willis R. The Spread of Tumors in the Human Body. London: Butterworth; 1973.
16. Berrettoni B. Mechanisms of cancer metastasis to bone. J Bone Joint Surg 1986; 68A: 308-12.
17. Coman D, Delong R. The role of the vetebral venous system in the metastasis of cancer to the spinal column. Cancer 1951; 4: 610-8.
18. Galasko C. Mechanisms of bone destruction in the development of skeletal metastases. Nature 1976; 263: 507-8.
19. Ingall J. A model for the study of experimental bone metastases. Proc Soc Exp Biol Med 1964; 117: 819-22.
20. Powles T, Clark S, Easty D et al. The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcemia in rats with Walker tumour and its possible application to human breast cancer. Br J Cancer 1973; 28(4): 316-21.
21. Murphy P, Alexander P, Senior P et al. Mechanisms of organ selective tumour growth by bloodborne cancer cells. Br J Cancer 1988; 57(1): 19-31.
22. Gohji K, Nakajima M, Fabra A et al. Regulation of gelatinase production in metastatic renal cell carcinoma by organ specific fibroblasts. Jpn J Cancer Res 1994; 85: 152-60.
23. Fabra A, Nakajima M, Bucana C et al. Modulation of the invasive phenotype of human colon carcinoma cells by organ specific fibroblasts of nude mice. Differentiation 1992; 52: 101-10.
24. Fidler I. Experimental orthotopic models of organ-specific metastasis by human neoplasms. Adv Mol Cell Biol 1994; 9: 191-215.
25. Berry K, Siegal G, Boyd J et al. Development of a metastatic model for human endometrial carcinoma using orthotopic implantation in nude mice. Int J Oncol 1994; 4: 1163-71.
26. Dinney C, Fishbeck R, Singh R et al. Isolation and characterization of metastatic variants from human transitional carcinoma passaged by orthotopic implantation in athymic nude mice. J Urol 1995; 154(4): 1532-8.
27. Stephenson R, Dinney C, Gohji K et al. Metastatic model for human prostate cancer using orthotopic implantation in nude mice. J Natl Cancer Inst 1992; 84: 951-7.
28. Kuo T, Kubota T, Watanabe M et al. Site-specific chemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcutaneously in SCID mice: The importance of orthotopic models to obtain relevant drug evaluation data. Anticancer Res 1993; 13(3): 627-30.
29. Dexter D, Kowalski H, Blazar B et al. Heterogeneity of tumor cell populations from a single mouse mammary tumor. J Natl Cancer Inst 1978; 38: 3174-81.
30. Telford W, King L, Fraker P. Evaluation of gluccocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif 1991; 24: 447-59.
31. Miller B, Roi L, Howard L et al. Quantitative selectivity of contact-mediated intercellular communication in a mouse mammary tumor line. Cancer Research 1983; 52: 1399-1405.
32. Miller F, Heppner G. Immunologic heterogeneity of tumor cell sub-populations from a single mouse mammary tumor. J Natl Cancer Inst 1979; 63(6): 1457-63.
33. Arguello F, Baggs R, Frantz C. A murine model of experimental metastases to bone and bone marrow. Cancer Res 1988; 48(23): 6876-81.
34. Dore J, Bailly M, Bertrand S. Metastases of human tumors in experimental animals. Anticancer Res 1987; 7(5B): 997-1003.
35. Urashima M, Chen B, Chen S et al. The development of a model for the homing of multiple myeloma cells to human bone marrow. Blood 1997; 90(2): 754-65.
36. Kjonniksen I, Nesland J, Pihl A et al. Nude rat model for studying metastasis of human tumor cells to bone and bone marrow. JNCI 1990; 82: 408-12.
37. Yoshino K, Tanabe M, Ohnuma N et al. Histopathological analysis of bone marrow and bone metastasis in murine neuroblastoma. Clin Exp Metastasis 1996; 14: 459-65.
38. Iwakawa K, Ando H, Koike S et al. A murine model for bone marrow metastases established by an iv injection of C-1300 neuroblastoma inA/J mice. Clin Exp Metastasis 1994; 12: 231-7.
39. Killion J, Radinsky R, Fidler I. Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev 1999;1 7: 279-84.
40. Naito S, von Eschenbach A, Fidler I. Different growth pattern and biological behavior of human renal cell carcinoma implanted into different organs of nude mice. J Natl Cancer Inst 1987; 78: 377-85.
41. Yamashina K, Heppner G. Correlation of frequency of induced mutation and metastatic potential in tumor cell lines from a single mouse mammary tumor. Cancer Res 1985; 45: 4015-9.
42. Miller F, Miller B, Heppner G. Characterization of metastatic heterogeneity amoung subpopulations of a single mouse mammary tumor: Heterogeneity in phenotypic stability. Invasion Metastasis 1983; 3: 22-31.
43. Gisselsson D, Pettersson L, Hoglund M et al. Chromosomal breakagefusion-bridge events cause genetic intratumor heterogeneity. PNAS 2000; 97(10): 5357-62.
44. Hahn P. Molecular biology of double-minute chromosomes. Bioessays 1993; 15(7): 477-84.
45. Miller F, Medina D, Heppner G. Preferential growth of mammary tumors in intact mammary fatpads. Cancer Res 1981; 41: 3863-7.
46. Farina K, Wyckoff J, Rivera J et al. Cell motility of tumor cells visualized in living intact primary tumors using green fluorescent protein. Cancer Res 1998; 58: 2528-32.
47. Kell M, Winter D, O'Sullivan G et al. Biological behavior and clinical implications of micrometastases. Br J Surg 2000; 87: 1629-39.
48. Funke I, Fries S, Rolle M et al. Comparative analysis of bone marrow micrometastases in breast and gastric cancer. Int J Cancer 1996; 65(6): 755-61.
49. Tsuchiya A, Sugano K, Kimijima I et al. Immunohistochemical evaluation of lymph node micrometastases from breast cancer. Acta Oncol 1996; 35: 425-8.
50. Chalfie M, Tu Y, Euskirchen G et al. Green fluorescent protein as a marker for gene expression. Science 1994; 263(5148): 802-5.
51. Prasher D, Eckenrode V, Ward W et al. Primary structure of the Aequorea victoria green-fluorescent protein. Gene 1992; 111(2): 229-33.
52. Liu H, Jan M, Chou C et al. Is green fluorescent protein toxic to the living cells? Biochem Biophys Res Commun 1999; 260: 712-7.
53. Culp L, Lin W, Kleinman N. Tagged tumor cells reveal regulatory steps during the earliest stages of tumor progression and micrometastasis. Histol Histopathol 1999; 14: 879-86.
54. Reed E, Murphy B, Tarantolo S et al. Tumor cells detected by immunocytochemistry (ICC) in autologous blood stem cell (BSC) harvests have no impact on outcome for breast cancer patients (PTS) with 4-9 nodes treated with adjuvant high dose chemotherapy (HDC) and stem cell rescue. ASCO 2001; 20: 17b (Abstr 1817).
55. Chambers A, Naumov G, Vantyghem S et al. Molecular biology of breast cancer metastasis clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Res 2000; 2: 400-7.
56. Talmadge J, Wolman S, Fidler I. Evidence for the clonal origin of spontaneous metastasis. Science 1982; 217: 361-3.
57. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86: 353-64.
58. Klauber-DeMore N, Van Zee K, Linkov I et al. Biological behavior of human breast cancer metastases. Clin Cancer Res 2001; 7: 2434-9.
59. Karrison T, Ferguson D, Meier P. Dormancy of mammary carcinoma after mastectomy. JNCI 1999; 91(1): 80-5.
60. Metzler A. Dormancy and breast cancer. J Surg Oncol 1990; 43: 181-8.
61. Murray C. Tumour dormancy: Not so sleepy after all. Nature Med 1995; 1: 117-8.